COVID-19 Second Wave in India – Wait or Act?

Abstract

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

The Reply

“…

We have read Dr Mohapatra's remarks on our commentary. 1 We would like to respond point by point:During the coronavirus disease 2019 (COVID-19) pandemic, many international organizations and even local authorities came up with treatment guidelines. We firmly believe that the pandemic was a war-like situation, and guidelines needed to be taken with a pinch of salt.An interesting letter was published in Lancet in 2007 titled "Guidelines on Guidelines."

…”

Remdesivir for Outpatient Management: Time to Wait, Not to Act

“…In their Commentary, Mardikar et al 1 describe their case conducted within one hospital where only 15 moderate risk patients with oxygen saturation ≥ 94% required neither actual hospitalisation nor remdesivir. None of the guidelines across the globe recommend remdesivir for patients having saturation ≥ 94% who can stay at home.…”